Natural and non-natural antioxidative compounds: potential candidates for treatment of vascular calcification
Autor: | Tzu-Hang Yuan, Hsiang-Yuan Yeh, Pei-Huan Chuang, Huei-Wen Chen, You-Tien Tsai, Chia-Ter Chao, Jenq-Wen Huang |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Cancer Research Antioxidant Vascular smooth muscle medicine.medical_treatment Immunology Review Article Disease 030204 cardiovascular system & hematology Bioinformatics medicine.disease_cause lcsh:RC254-282 Calcification 03 medical and health sciences Cellular and Molecular Neuroscience 0302 clinical medicine medicine lcsh:QH573-671 chemistry.chemical_classification Reactive oxygen species NADPH oxidase biology business.industry lcsh:Cytology Wnt signaling pathway Cell Biology medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens 030104 developmental biology chemistry biology.protein business Oxidative stress |
Zdroj: | Cell Death Discovery, Vol 5, Iss 1, Pp 1-11 (2019) Cell Death Discovery |
ISSN: | 2058-7716 |
DOI: | 10.1038/s41420-019-0225-z |
Popis: | Vascular calcification (VC) is highly prevalent in patients with advanced age, or those with chronic kidney disease and diabetes, accounting for substantial global cardiovascular burden. The pathophysiology of VC involves active mineral deposition by transdifferentiated vascular smooth muscle cells exhibiting osteoblast-like behavior, building upon cores with or without apoptotic bodies. Oxidative stress drives the progression of the cellular phenotypic switch and calcium deposition in the vascular wall. In this review, we discuss potential compounds that shield these cells from the detrimental influences of reactive oxygen species as promising treatment options for VC. A comprehensive summary of the current literature regarding antioxidants for VC is important, as no effective therapy is currently available for this disease. We systematically searched through the existing literature to identify original articles investigating traditional antioxidants and novel compounds with antioxidant properties with regard to their effectiveness against VC in experimental or clinical settings. We uncovered 36 compounds with antioxidant properties against VC pathology, involving mechanisms such as suppression of NADPH oxidase, BMP-2, and Wnt/β-catenin; anti-inflammation; and activation of Nrf2 pathways. Only two compounds have been tested clinically. These findings suggest that a considerable opportunity exists to harness these antioxidants for therapeutic use for VC. In order to achieve this goal, more translational studies are needed. |
Databáze: | OpenAIRE |
Externí odkaz: |